Template:Appendicitis Antibiotics: Difference between revisions

Line 23: Line 23:
**[[Ciprofloxacin]] 400mg IV q12hrs OR
**[[Ciprofloxacin]] 400mg IV q12hrs OR
**[[Levofloxacin]] 750mg IV q24hrs
**[[Levofloxacin]] 750mg IV q24hrs
**[[Aztreoname]] 30mg/kg IV q8hrs
**[[Aztreonam]] 30mg/kg IV q8hrs
*[[Imipenem/Cilastatin]] 25mg/kg IV q6hrs (max 500mg)
*[[Imipenem/Cilastatin]] 25mg/kg IV q6hrs (max 500mg)
*[[Meropenem]] 20mg/kg IV q8hrs (max 1g)
*[[Meropenem]] 20mg/kg IV q8hrs (max 1g)
*[[Piperacillin/Tazobactam]] 100mg/kg (max 4.5g) IV q8hrs
*[[Piperacillin/Tazobactam]] 100mg/kg (max 4.5g) IV q8hrs
''Cautious use should be applied to use of fluoroquinolones in complicated pediatric appendicitis due to the risk of tendon injury''
''Cautious use should be applied to use of fluoroquinolones in complicated pediatric appendicitis due to the risk of tendon injury''

Revision as of 20:15, 14 April 2015

Coverage should extend to E. coli, Klebsiella, Proteus, and Bacteroides (an anaerobe)

Adult Simple Appendicitis

Antibiotic prophylaxis should be coordinated with surgical consult Options:

Pediatric Simple Appendicitis

Options:

Complicated Appendicitis

Defined as perforation, abscess, or phlegmon Options:

Cautious use should be applied to use of fluoroquinolones in complicated pediatric appendicitis due to the risk of tendon injury